MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03942naaaa2200793uu 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
https://directory.doabooks.org/handle/20.500.12854/69449 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20220714194602.0 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
books978-3-03943-624-8 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039436231 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9783039436248 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.3390/books978-3-03943-624-8 |
| Terms of availability |
doi |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
English |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
dc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
M |
| Source |
bicssc |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Saiz, Juan Carlos |
| Relator code |
edt |
| 9 (RLIN) |
1622328 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Vaccines against RNA Viruses |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Basel, Switzerland |
| Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
| Date of publication, distribution, etc |
2020 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 electronic resource (166 p.) |
| 506 0# - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Open Access |
| Source of term |
star |
| Standardized terminology for access restriction |
Unrestricted online access |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
RNA viruses cause animal, human, and zoonotic diseases that affect millions of individuals, as is being exemplified by the devastating ongoing epidemic of the recently identified SARS-Cov-2. For years vaccines have had an enormous impact on overcoming the global burden of diseases. Nowadays, a vast number of different approaches, from purified inactivated and live attenuated viruses, nucleic acid (DNA or RNA) based candidates, virus-like particles, subunit elements, and recombinant viruses are been employed to combat viruses. However, for many of them efficient vaccines are not yet available. This will probably change dramatically with the current Covid-19 pandemic, as a vast variety of vaccinology approaches are being tested against it, with hundreds of candidates under development, dozens of them already in clinical trials, a fact that is breaking records in vaccine development and implementation. This is becoming possible thanks to the enormous work carried out during years to have the bases for a quick response, even against unknown pathogens, in an impressive short time. Here, results obtained with different vaccine´s methodological approaches against human (HIV, HCV, HRV) animal (PRRSV, PEDV, FMDV, VHSV) and zoonotic (RVF, WNV), RNA viruses are presented by field experts. |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
|---|
| Terms governing use and reproduction |
Creative Commons |
| -- |
https://creativecommons.org/licenses/by/4.0/ |
| -- |
cc |
| -- |
https://creativecommons.org/licenses/by/4.0/ |
| 546 ## - LANGUAGE NOTE |
|---|
| Language note |
English |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicine |
| Source of heading or term |
bicssc |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
artificial protein |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
polyepitope B- and T-cell HIV-1 immunogen |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
epitopes of broadly neutralizing HIV-1 antibodies |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
peptide mimic of discontinuous epitope |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
immunogenicity |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
birds |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
vaccines |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
West Nile virus |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
flavivirus |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
herd immunity |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
porcine epidemic diarrhea virus |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
RNA interference |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
processivity factor |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
intestine epithelial cells |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
N gene |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
rotavirus nanoparticle vaccine |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
gnotobiotic pigs |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
FMDV |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
peptide vaccine |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
single dose |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
amount |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
pig |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
VHSV |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
non-virion (NV) |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
transcriptome profiling |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
rainbow trout |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
immune pathways |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Rift Valley fever virus (RVFV) |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
modified vaccinia Ankara (MVA) |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cellular response |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
neutralizing antibodies |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
Gn Gc glycoproteins |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
passive serum:virus transfer |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
hepatitis C virus |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
neutralising antibodies |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
animal models |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
immune responses |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
PRRSV Mosaic T-cell DNA vaccine VACV |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
PRRS |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
cross protection |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
heterologous virus challenge |
| 653 ## - INDEX TERM--UNCONTROLLED |
|---|
| Uncontrolled term |
n/a |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Saiz, Juan Carlos |
| Relator code |
oth |
| 9 (RLIN) |
1622328 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/3253">https://mdpi.com/books/pdfview/book/3253</a> |
| -- |
0 |
| Public note |
DOAB: download the publication |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Host name |
www.oapen.org |
| Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/69449">https://directory.doabooks.org/handle/20.500.12854/69449</a> |
| -- |
0 |
| Public note |
DOAB: description of the publication |
